Astrazeneca (AZN) Prepaid Assets (2015 - 2025)

Astrazeneca (AZN) has reported Prepaid Assets for 11 consecutive years, with $2.0 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Prepaid Assets rose 17.1% year-over-year to $2.0 billion; the TTM figure through Dec 2025 stood at $2.0 billion (up 17.1% YoY), while the FY2025 annual figure was $2.0 billion, up 17.1% from the prior year.
• Prepaid Assets came in at $2.0 billion for Q4 2025 at Astrazeneca, up from $1.7 billion in the prior quarter.
• The five-year high for Prepaid Assets was $2.0 billion in Q4 2025, with the low at -$706.0 million in Q1 2021.
• Average Prepaid Assets over 5 years is $1.3 billion, with a median of $1.6 billion recorded in 2021.
• Across the five-year window, Prepaid Assets decreased 12.85% in 2021 and grew 21.67% in 2023, its largest moves.
• Year by year, Prepaid Assets stood at $1.5 billion in 2021, then fell by 12.1% to $1.3 billion in 2022, then rose by 21.67% to $1.6 billion in 2023, then rose by 7.42% to $1.7 billion in 2024, then advanced by 17.1% to $2.0 billion in 2025.
• According to Business Quant data, Prepaid Assets over the past three periods registered $2.0 billion, $1.7 billion, and $1.6 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.